CYTOKINETICS, INCORPORATED Common Stock (par value $0.001 per share) At the Market Issuance Sales AgreementAt the Market Issuance Sales Agreement • June 13th, 2011 • Cytokinetics Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 13th, 2011 Company Industry JurisdictionCytokinetics, Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (“MLV”), as follows: